Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysis

Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysis

Abstract Purpose Numerous clinical studies have explored sodium–glucose cotransporter 2 inhibitor (SGLT2i) in patients with chronic heart failure (CHF), with or without type 2 diabetes mellitus (T2DM), and SGLT2i were proved to significantly reduce CHF hospitalization, cardiovascular death, cardiova...

Full description

Bibliographic Details
Main Authors: Jiao Chen, Chunxia Jiang, Man Guo, Yan Zeng, Zongzhe Jiang, Dongmin Zhang, Mengqin Tu, Xiaozhen Tan, Pijun Yan, XunMei Xu, Yang Long, Yong Xu
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Cardiovascular Diabetology
Subjects:
SGLT2 inhibitors
Cardiac function
Health status
Chronic Heart Failure
Meta-analysis
Online Access:https://doi.org/10.1186/s12933-023-02042-9

Internet

https://doi.org/10.1186/s12933-023-02042-9

Similar Items